Should the Angiotensin II Antagonists be Discontinued Before Surgery?
Authors:
- Gilles GodetGGGilles Godet
- Karolin MeersschaertKMKarolin Meersschaert
- Luc BrunLBLuc Brun
- Eduardo SalcedoESEduardo Salcedo
- Pierre CoriatPCPierre Coriat
- 1 January 2001
- journal article
- clinical trial
- Published by Wolters Kluwer Health in Anesthesia & Analgesia
- Vol. 92 (1) , 26-30
Abstract
Angiotensin II antagonists (AIIA) are part of a new rational treatment of hypertension. Because adverse circulatory effects during anesthesia can occur in patients chronically treated with angiotensin-converting enzyme inhibitors, some clinicians discontinue them at least 24 h before operation. No data are available concerning AIIA administration in patients scheduled for vascular surgery performed under general anesthesia. The aim of this prospective randomized study was to compare hemodynamics during induction of anesthesia in patients chronically treated with AIIA and those of patients not receiving this drug on the morning before operation. Thirty-seven patients chronically treated with AIIA for hypertension were randomly assigned to two groups: Group I: AIIA discontinued on the day before surgery (n = 18); Group II: AIIA given 1 h before anesthesia (n = 19). Patients received sufentanil 0.4 μg/kg, propofol 1.5 mg/kg, and atracurium 0.5 mg/kg. During the procedure, the anesthesiologist was required to maintain systolic blood pressure and heart rate within 30% of baseline values using intravascular fluid administration and vasoconstric- tors (e.g., ephedrine, phenylephrine, or terlipressin). Hemodynamic variables were recorded each 1 min. Hemodynamic study ended at incision. The number and duration of hemodynamic events were collected, and total doses of vasoactive drugs were noted in each group. Systolic arterial pressure was significantly decreased in Group II at 5, 15 and 23 min after induction of anesthesia (*P < 0.05). In this group, the decrease in systolic arterial pressure was associated with more frequent episodes of hypotension (AIIA withdrawn: 1 ± 1; AIIA given: 2 ± 1;P < 0.01), with a larger number of patients developing at least 1 episode of hypotension (AIIA withdrawn: 12; AIIA given: 19;P < 0.01), and a longer duration of an episode of hypotension (AIIA withdrawn: 3 ± 4 min; AIIA given: 8 ± 7 min;P < 0.01), and an increased need for vasoactive drugs. In conclusion, blockade of the renin-angiotensin system increases the potential hypotensive effect of anesthetic induction. A severe hypotensive episode, requiring vasoconstrictor treatment, occurs after induction of general anesthesia in patients chronically treated with AIIA. Recommendations to discontinue AIIA drugs on the day before the surgery may be justified. This prospective randomized study demonstrated that more severe hypotensive episodes, requiring vasoconstrictor treatment, occur after induction of general anesthesia in patients chronically treated with AIIA and receiving this drug on the morning before operation, in comparison with those in whom AIIA were discontinued on the day before operation. Recommendations to discontinue these drugs on the day before the surgery may be justified.Keywords
This publication has 13 references indexed in Scilit:
- The Hemodynamic Effects of Anesthetic Induction in Vascular Surgical Patients Chronically Treated with Angiotensin II Receptor AntagonistsAnesthesia & Analgesia, 1999
- Refractory Hypotension After Induction of Anesthesia in a Patient Chronically Treated with Angiotensin Receptor AntagonistsAnesthesia & Analgesia, 1999
- Treating Anesthesia-Induced Hypotension by Angiotensin II in Patients Chronically Treated with Angiotensin-Converting Enzyme InhibitorsAnesthesia & Analgesia, 1998
- IrbesartanDrugs, 1997
- Hemodynamic Effects of Anesthesia in Patients with Ischemic Heart Failure Chronically Treated with Angiotensin-Converting Enzyme InhibitorsAnesthesia & Analgesia, 1997
- Renal Circulation and Blockade of the Renin-Angiotensin SystemHypertension, 1995
- Influence of Chronic Angiotensin-converting Enzyme Inhibition on Anesthetic InductionAnesthesiology, 1994
- Angiotensin II Receptor Blockade: An Innovative Approach to Cardiovascular PharmacotherapyThe Journal of Clinical Pharmacology, 1993
- Anesthetic Implications of the Renin-Angiotensin System and Angiotensin-Converting Enzyme InhibitorsAnesthesia & Analgesia, 1991
- The use of angiotensin II to treat profound hypotension in a patient taking amiodaroneJournal of Cardiothoracic Anesthesia, 1990